Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 May 2010

Onitsuka Takamitsu, Uramoto Hidetaka, Ono Kenji, Takenoyama Mitsuhiro, Hanagiri Takeshi, Oyama Tsunehiro, Izumi Hiroto, Kohno Kimitoshi, Yasumoto Kosei

Abstract excerpt

BACKGROUND: The mutation and amplification of oncogenic genes are associated with carcinogenesis and tumor growth. The purpose of this study was to clarify the role of the epidermal growth factor receptor (EGFR), K-ras, MET, and hepatocyte growth factor (HGF) status in lung adenocarcinoma. METHOD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Neoplasm
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatocyte Growth Factor

Share to Immunoenzyme Techniques

Share to Proto-Oncogene Proteins c-met

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Receptors, Growth Factor

Source

Identifiers

PMID: 20150826
DOI: 10.1097/JTO.0b013e3181d0a4db

Genes

MET
HGF
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20150826-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.PMID 20150826Read ↗

Expression and mutational analysis of MET in human solid cancers.Semantic proximity Read ↗

HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer.Semantic proximity Read ↗

MET amplification, protein expression, and mutations in pulmonary adenocarcinoma.Semantic proximity Read ↗

Role of c-Met in cancer: emphasis on lung cancer.Semantic proximity Read ↗

Prognostic and predictive value of MET deregulation in non-small cell lung cancer.Semantic proximity Read ↗

Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers.Semantic proximity Read ↗

Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?Semantic proximity Read ↗

Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer.Semantic proximity Read ↗

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines.Semantic proximity Read ↗

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.Semantic proximity Read ↗

Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.Semantic proximity Read ↗

Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.